Annual EBITDA
-$262.83 M
-$11.40 M-4.54%
December 31, 2024
Summary
- As of March 10, 2025, NMRA annual EBITDA is -$262.83 million, with the most recent change of -$11.40 million (-4.54%) on December 31, 2024.
- During the last 3 years, NMRA annual EBITDA has fallen by -$26.05 million (-11.00%).
- NMRA annual EBITDA is now -175.47% below its all-time high of -$95.41 million, reached on December 1, 2020.
Performance
NMRA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$62.77 M
+$13.72 M+17.94%
December 31, 2024
Summary
- As of March 10, 2025, NMRA quarterly EBITDA is -$62.77 million, with the most recent change of +$13.72 million (+17.94%) on December 31, 2024.
- Over the past year, NMRA quarterly EBITDA has stayed the same.
- NMRA quarterly EBITDA is now -309.88% below its all-time high of -$15.31 million, reached on March 1, 2021.
Performance
NMRA Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$262.83 M
+$51.07 M+16.27%
December 31, 2024
Summary
- As of March 10, 2025, NMRA TTM EBITDA is -$262.83 million, with the most recent change of +$51.07 million (+16.27%) on December 31, 2024.
- Over the past year, NMRA TTM EBITDA has stayed the same.
- NMRA TTM EBITDA is now -1250.29% below its all-time high of -$19.46 million, reached on December 1, 2020.
Performance
NMRA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
NMRA EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -4.5% | 0.0% | 0.0% |
| 3 y3 years | -11.0% | 0.0% | 0.0% |
| 5 y5 years | - | 0.0% | 0.0% |
NMRA EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -94.3% | at low | -106.1% | +44.9% | -100.5% | +16.3% |
| 5 y | 5-year | -175.5% | at low | -309.9% | +64.7% | -1250.3% | +16.3% |
| alltime | all time | -175.5% | at low | -309.9% | +64.7% | -1250.3% | +16.3% |
Neumora Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$262.83 M(+4.5%) | -$62.77 M(-17.9%) | -$262.83 M(-16.3%) |
| Sep 2024 | - | -$76.49 M(+20.2%) | -$313.91 M(+6.7%) |
| Jun 2024 | - | -$63.66 M(+6.3%) | -$294.11 M(+8.0%) |
| Mar 2024 | - | -$59.92 M(-47.4%) | -$272.34 M(+8.3%) |
| Dec 2023 | -$251.43 M(+85.9%) | -$113.84 M(+100.8%) | -$251.43 M(+49.5%) |
| Sep 2023 | - | -$56.69 M(+35.3%) | -$168.16 M(+18.5%) |
| Jun 2023 | - | -$41.89 M(+7.4%) | -$141.93 M(+8.2%) |
| Mar 2023 | - | -$39.01 M(+27.6%) | -$131.20 M(-3.0%) |
| Dec 2022 | -$135.28 M | -$30.57 M(+0.4%) | -$135.28 M(+3.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$30.46 M(-2.3%) | -$131.12 M(-52.9%) |
| Jun 2022 | - | -$31.16 M(-27.7%) | -$278.65 M(+5.3%) |
| Mar 2022 | - | -$43.09 M(+63.1%) | -$264.56 M(+11.7%) |
| Dec 2021 | -$236.78 M(+148.2%) | - | - |
| Dec 2021 | - | -$26.42 M(-85.2%) | -$236.78 M(+3.0%) |
| Sep 2021 | - | -$177.98 M(+942.3%) | -$229.83 M(+343.2%) |
| Jun 2021 | - | -$17.07 M(+11.5%) | -$51.85 M(+49.1%) |
| Mar 2021 | - | -$15.31 M(-21.3%) | -$34.78 M(+78.7%) |
| Dec 2020 | -$95.41 M | -$19.46 M | -$19.46 M |
FAQ
- What is Neumora Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for Neumora Therapeutics?
- What is Neumora Therapeutics annual EBITDA year-on-year change?
- What is Neumora Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Neumora Therapeutics?
- What is Neumora Therapeutics quarterly EBITDA year-on-year change?
- What is Neumora Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Neumora Therapeutics?
- What is Neumora Therapeutics TTM EBITDA year-on-year change?
What is Neumora Therapeutics annual EBITDA?
The current annual EBITDA of NMRA is -$262.83 M
What is the all time high annual EBITDA for Neumora Therapeutics?
Neumora Therapeutics all-time high annual EBITDA is -$95.41 M
What is Neumora Therapeutics annual EBITDA year-on-year change?
Over the past year, NMRA annual EBITDA has changed by -$11.40 M (-4.54%)
What is Neumora Therapeutics quarterly EBITDA?
The current quarterly EBITDA of NMRA is -$62.77 M
What is the all time high quarterly EBITDA for Neumora Therapeutics?
Neumora Therapeutics all-time high quarterly EBITDA is -$15.31 M
What is Neumora Therapeutics quarterly EBITDA year-on-year change?
Over the past year, NMRA quarterly EBITDA has changed by $0.00 (0.00%)
What is Neumora Therapeutics TTM EBITDA?
The current TTM EBITDA of NMRA is -$262.83 M
What is the all time high TTM EBITDA for Neumora Therapeutics?
Neumora Therapeutics all-time high TTM EBITDA is -$19.46 M
What is Neumora Therapeutics TTM EBITDA year-on-year change?
Over the past year, NMRA TTM EBITDA has changed by $0.00 (0.00%)